| General Information of This Metabolic Reaction (MR) (ID:
MR006449) |
| Formula |
|
| Reactant |
SC-15090 |
Product |
3-MX |
|
Reactant Info
|
Product Info
|
|
Metabolic Type
|
Oxidation
-
N3-demethylation
|
|
|
|
|
|
|
|
| Other MR(s) Related to The Reactant of This MR |
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
|
| Other MR(s) Related to The Product of This MR |
|
Other MR(s) That Produce The Product of This MR
|
|
|
| References |
| 1 |
Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors. J Clin Pharmacol. 2009 Jan;49(1):17-29.
|
| 2 |
Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism. Br J Clin Pharmacol. 1999 Mar;47(3):299-305.
|
| 3 |
Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma Clin Pharmacol Ther. 2003 May;73(5):468-74. doi: 10.1016/s0009-9236(03)00013-4.
|
| 4 |
Theophylline metabolism in human liver microsomes: inhibition studies. J Pharmacol Exp Ther. 1996 Mar;276(3):912-7.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.